Eli Lilly

Eli Lilly

Discovery, development, manufacture, and sale of products in pharmaceutical products business segment. Learn more

Launch date
Employees
Market cap
€765.4b
Enterprise valuation
€788.6b (Public information from Sep 2024)
Indianapolis Indiana (HQ)
Corporate Venture Fund: Lilly Ventures

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues24.5b28.3b28.5b34.1b46.3b57.1b68.0b
% growth10 %15 %1 %20 %36 %23 %19 %
EBITDA7.6b8.7b9.4b12.5b18.9b25.3b32.1b
% EBITDA margin31 %31 %33 %37 %41 %44 %47 %
Profit6.2b5.6b6.2b5.2b13.9b18.8b24.7b
% profit margin25 %20 %22 %15 %30 %33 %36 %
EV / revenue6.8x9.3x12.7x16.0x19.1x15.4x12.8x
EV / EBITDA21.7x30.1x38.3x43.9x47.0x34.8x27.0x
R&D budget6.1b7.0b7.2b9.3b---
R&D % of revenue25 %25 %25 %27 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
-

N/A

-

$16.5m

Series A
N/A

$9.2m

Early VC
N/A

N/A

IPO
*

N/A

Acquisition

$375m

Grant

$813m

Grant
*
N/A

$6.0b

Post IPO Debt
Total Funding€1.1b

Recent News about Eli Lilly

Edit
More about Eli Lillyinfo icon
Edit

Eli Lilly and Company, commonly known as Lilly, is a global pharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that improve lives. Founded over 140 years ago, Lilly has a rich history of scientific breakthroughs, including the development of the first life-saving treatment for diabetes, insulin. The company operates in the healthcare and pharmaceutical market, focusing on creating treatments for various medical conditions.

Lilly serves a diverse range of clients, including healthcare professionals, hospitals, clinics, and patients worldwide. The company’s business model revolves around extensive research and development (R&D) to create new medicines, followed by manufacturing and distributing these products globally. Lilly invests heavily in R&D to discover new treatments and improve existing ones, ensuring they meet the highest standards of safety and efficacy.

The company makes money primarily through the sale of its prescription medicines. These products are sold to healthcare providers, who then prescribe them to patients. Lilly’s portfolio includes treatments for diabetes, cancer, immunology, pain management, and other serious health conditions. Additionally, Lilly collaborates with various partners, including Team USA, to promote health and wellness initiatives.

Lilly is also vigilant about protecting its products from counterfeiting and ensuring the availability of its medicines, such as tirzepatide and dulaglutide, which are crucial for managing diabetes. The company emphasizes its commitment to ethical practices, stating that it never asks for money in exchange for employment or investment opportunities.

In summary, Lilly is a leading pharmaceutical company dedicated to making life better through innovative medical solutions, serving a global market with a focus on quality and ethical standards.

Keywords: pharmaceutical, diabetes, insulin, R&D, healthcare, prescription medicines, innovation, global, ethical, treatments.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
  • Edit
ARMO Bio Sciences
ACQUISITION by Eli Lilly May 2018
Loxo Oncology
ACQUISITION by Eli Lilly Jan 2019
Alnara Pharmaceuticals
ACQUISITION by Eli Lilly Jul 2010
Zymeworks
exited
ImmunoGen
ACQUISITION by AbbVie Nov 2023
View 122 more